Perkin Elmer releases white paper on digital transformation
Digitization

Perkin Elmer releases white paper on digital transformation

The paper suggests that a good digital transformation strategy is uniquely influenced by a company’s own business objectives. Click Here to download the white paper.

  • By ICN Bureau | April 09, 2021

With large scale consolidation expected in the market, the winners will be the ones who can scale up efficiently as well as effectively – working smarter, rather than simply working harder or adding more capacity by hiring additional employees

Perkin Elmer, a company focused on delivering unique solutions to serve the diagnostics, life sciences, food and applied markets, has released a whitepaper on "The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation" for the pharma and specialty chemical sector.

India’s pharma sector is undergoing significant growth and is expected to reach US $70 billion in 2020. With large scale consolidation expected in the market, the winners will be the ones who can scale up efficiently as well as effectively – working smarter, rather than simply working harder or adding more capacity by hiring additional employees.

The white paper suggests that a good digital transformation strategy is uniquely influenced by a company’s own business objectives. But, the best of them should hold a few key attributes such as shared vision, adaptability, harmonization and standardization across all internal teams and clear direction to compel forward action, amongst others. Also, companies need built-in agility to respond to shifting needs and opportunities in the market.

Talking about implementations of digital applications in labs, the case study shows efficiency improvements can range between 25 to 30 percent–an efficiency that cannot be attained simply by adding more resources to a lab. When one factor in the routine administrative tasks that can be replaced by aligning digital applications, the time saving increases to about 40 percent. In real terms, that means not just improved process efficiency, but faster product development, a more agile response to the demands to develop the new generic drug, and a shorter time to market, overall.

The white paper also talks about how one of the large multinational generics drug companies headquartered in India implemented PerkinElmer’s E-Notebook where each piece of the data related to the experiment was considered from the perspective of its utility and the strategy for digitization was devised accordingly.

To download the whitepaper, click here

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy